Register
Medicines reference
Product

ANTIHELM TRIO

Fenbendazole + Pyrantel + Praziquantel · Vetsintez Ltd

1 form: scored tablet. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
Scored tablet · Cat 1–2.5 kg Cat 1–2.5 kg 1/4 tablet
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
· once; repeat after 10-14 days only when clinically indicated
once; repeat after 10-14 days only when clinically indicated Georgia Yes, veterinary
In force until 05 Aug 2031
Veterinary (National Food Agency)
In the register: ანტიჰელმი ტრიო 0.8 გ
№ 001234
Verified on: 23 Oct 2026
Scored tablet · Cat 2.5–5 kg Cat 2.5–5 kg 1/2 tablet
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
· once; repeat after 10-14 days only when clinically indicated
once; repeat after 10-14 days only when clinically indicated Georgia Yes, veterinary
In force until 05 Aug 2031
Veterinary (National Food Agency)
In the register: ანტიჰელმი ტრიო 0.8 გ
№ 001234
Verified on: 23 Oct 2026
Scored tablet · Cat 5–10 kg Cat 5–10 kg 1 tablet
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
· once; repeat after 10-14 days only when clinically indicated
once; repeat after 10-14 days only when clinically indicated Georgia Yes, veterinary
In force until 05 Aug 2031
Veterinary (National Food Agency)
In the register: ანტიჰელმი ტრიო 0.8 გ
№ 001234
Verified on: 23 Oct 2026
Scored tablet · Cat over 10 kg Cat over 10 kg 1 tablet per 10 kg
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
· once; repeat after 10-14 days only when clinically indicated
once; repeat after 10-14 days only when clinically indicated Georgia Yes, veterinary
In force until 05 Aug 2031
Veterinary (National Food Agency)
In the register: ანტიჰელმი ტრიო 0.8 გ
№ 001234
Verified on: 23 Oct 2026
Scored tablet · Dog 1–2.5 kg Dog 1–2.5 kg 1/4 tablet
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
· once; repeat after 10-14 days only when clinically indicated
once; repeat after 10-14 days only when clinically indicated Georgia Yes, veterinary
In force until 05 Aug 2031
Veterinary (National Food Agency)
In the register: ანტიჰელმი ტრიო 0.8 გ
№ 001234
Verified on: 23 Oct 2026
Scored tablet · Dog 2.5–5 kg Dog 2.5–5 kg 1/2 tablet
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
· once; repeat after 10-14 days only when clinically indicated
once; repeat after 10-14 days only when clinically indicated Georgia Yes, veterinary
In force until 05 Aug 2031
Veterinary (National Food Agency)
In the register: ანტიჰელმი ტრიო 0.8 გ
№ 001234
Verified on: 23 Oct 2026
Scored tablet · Dog 5–10 kg Dog 5–10 kg 1 tablet
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
· once; repeat after 10-14 days only when clinically indicated
once; repeat after 10-14 days only when clinically indicated Georgia Yes, veterinary
In force until 05 Aug 2031
Veterinary (National Food Agency)
In the register: ანტიჰელმი ტრიო 0.8 გ
№ 001234
Verified on: 23 Oct 2026
Scored tablet · Dog over 10 kg Dog over 10 kg 1 tablet per 10 kg
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
· once; repeat after 10-14 days only when clinically indicated
once; repeat after 10-14 days only when clinically indicated Georgia Yes, veterinary
In force until 05 Aug 2031
Veterinary (National Food Agency)
In the register: ანტიჰელმი ტრიო 0.8 გ
№ 001234
Verified on: 23 Oct 2026
Details: pack, label wording, sources, registration

ANTIHELM TRIO, Scored tablet

fenbendazole 200 mg + pyrantel pamoate 144 mg + praziquantel 50 mg, tablet for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Complete manufacturer-labelled canine scope: prevention/treatment of listed nematodes, cestodes and trematodes plus claimed Giardia activity
6.3/10
Situational / acceptable
vetman assessment

ANTIHELM TRIO

fenbendazole 200 mg + pyrantel pamoate 144 mg + praziquantel 50 mg, tablet for dogs and cats
Assessed clinical scopeDog · Complete manufacturer-labelled canine scope: prevention/treatment of listed nematodes, cestodes and trematodes plus claimed Giardia activity · By mouth
Care settingVeterinary risk/diagnosis-led deworming after accurate weighing, with parasite/life-cycle-specific repeat decisions, reinfection control and efficacy testing when failure/resistance is plausible
vetman score 6.3/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 001234 · Verified on 23 Oct 2026

A situational broad-spectrum dog tablet with a credible narrower mixed GI nematode+cestode core, convenient dosing and substantial claim inflation beyond the matching EU evidence. Giardia, trematode, broad larval-stage and blanket prevention claims should not drive use without parasite-specific evidence and regimen.

Regulatory and scientific credibility6.5/10

Exact identity, dog use and dose are supported by current Georgian and Moldovan registrations plus manufacturer instructions; identical-strength EU dog products provide a strong narrower regulatory control. No exact international regulator SPC or public modern assessment supports the much broader Giardia/trematode/prevention claims.

Clinical efficacy5.0/10

Praziquantel/pyrantel/fenbendazole at 5/14.4/20 mg/kg has a current identical-strength EU dog authorisation for defined mixed GI nematode+cestode stages, so that narrower core is credible. The manufacturer extends one dose to larval stages, Strongyloides, prevention, several trematodes and Giardia without direct exact-product outcomes; a single 20 mg/kg fenbendazole exposure is not a guideline Giardia course.

Safety and tolerability6.5/10

The manufacturer reports no signs at 3-5x dose and twice-duration exposure in dogs, and the active classes are generally well tolerated. Confidence is limited by no independent exact safety report, broad organ/illness/reproductive exclusions and cholinergic interactions; GI or nonspecific reactions remain possible.

Clinical practicality8.0/10

One dose, no fasting, direct/food administration, quarter scoring and individual sachets are convenient. Accurate weighing and deliverable quarter increments remain necessary above 10 kg; repeat/quarterly prevention requires a parasite-risk plan rather than automatic calendar use.

Full-course cost-effectiveness-

Current Georgian course price was unavailable; price is excluded from the denominator.

Important safety and use flags

  • Scope boundary: this dog score covers the complete manufacturer-labelled nematode, cestode, trematode, prevention and claimed Giardia scope. Evidence is materially stronger for a narrower GI nematode+cestode core; presence of an active does not validate every listed organism/stage.
  • Diagnose/risk-assess before dosing: use faecal testing, visible segments, exposure and local epidemiology as appropriate. Echinococcus requires public-health procedures; severe hookworm disease may need stabilization and suspected treatment failure needs quantitative follow-up.
  • Exact dose: accurately weigh; give 1/4 tablet at 1-2.5 kg, 1/2 at >2.5-5 kg, 1 at >5-10 kg, then 0.1 tablet/kg in deliverable quarter increments. Give once directly or with food; no fasting/laxative. Do not round an undeliverable result.
  • Giardia boundary: one tablet/10 kg supplies fenbendazole 20 mg/kg once. This is not the multi-day fenbendazole-containing regimen described by current giardiosis guidance; do not diagnose/treat Giardia from the ingredient list or repeat empirically without diagnostic and hygiene control.
  • Broad-claim boundary: identical-strength EU dog products restrict use to defined mixed GI nematode+cestode stages and when both groups need treatment. Strongyloides, trematodes, broad larval stages and blanket prevention in this manufacturer label lack an equivalent exact-product public outcome dossier.
  • Repeat/prevention: repeat after 10-14 days only when parasite biology, diagnosis or risk indicates. Routine quarterly use is not universally optimal; tailor lifetime control to age, geography, hunting/raw diet, travel, household and faecal surveillance, limiting unnecessary selection pressure.
  • Reinfection/resistance: control fleas for Dipylidium, prey/raw offal for Taenia/Echinococcus and faecal/environment contamination. Persistent eggs/signs require adherence, reinfection, species/stage and resistance assessment—not automatic use of the same combination.
  • Do not use below 4 weeks in dogs or 6 weeks in cats, from one week before through two weeks after parturition, or in infectious disease, exhaustion/debilitation, renal/hepatic impairment or hypersensitivity. Lactation is allowed only once offspring exceed those age limits.
  • Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines. Stop/reassess clinically significant vomiting, diarrhoea, anorexia, lethargy, depression or neurologic/cholinergic signs; no specific overdose antidote is stated.
  • Dog overdose/handling boundary: manufacturer tolerance at 3-5x in dogs is not permission to round or stack products. Confirm full ingestion, keep each sachet from children/animals, wash hands and review all concurrent parasite preventives to avoid duplicate actives.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Complete manufacturer-labelled feline scope: prevention/treatment of listed nematodes, cestodes and trematodes plus claimed Giardia activity
5.3/10
Weak evidence support
vetman assessment

ANTIHELM TRIO

fenbendazole 200 mg + pyrantel pamoate 144 mg + praziquantel 50 mg, tablet for dogs and cats
Assessed clinical scopeCat · Complete manufacturer-labelled feline scope: prevention/treatment of listed nematodes, cestodes and trematodes plus claimed Giardia activity · By mouth
Care settingVeterinary risk/diagnosis-led deworming after accurate weighing, with parasite/life-cycle-specific repeat decisions, reinfection control and efficacy testing when failure/resistance is plausible
vetman score 5.3/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 001234 · Verified on 23 Oct 2026

A weak feline option despite local authorisation: key active classes are plausible, but the exact one-dose broad cat scope lacks an international exact-product evidence bridge and the manufacturer flags greater feline overdose sensitivity. Prefer parasite-specific, regulator-supported feline regimens when available.

Regulatory and scientific credibility6.0/10

Exact local cat registration and manufacturer directions are corroborated by Moldova; authorised EU cat/dog three-active products exist but differ in fenbendazole strength/presentation. No exact internationally regulated feline bridge or public assessment supports the full extended scope.

Clinical efficacy3.5/10

Praziquantel and pyrantel support important feline cestode/nematode endpoints, and other regulated cat/dog triple products support class plausibility. However, no exact-composition feline outcome/authorisation bridge validates the one-dose broad larval, Strongyloides, trematode, prevention or Giardia scope; weight bands also create variable exposure in small cats.

Safety and tolerability5.5/10

The manufacturer explicitly states cats are more overdose-sensitive and may develop depression, vomiting or diarrhoea, without a specific antidote. Quarter-band exposure rises at the low end, and age, periparturient, organ-disease, illness/debilitation and cholinergic-interaction exclusions materially narrow safe use.

Clinical practicality7.0/10

One dose, no fasting, food administration and quarter scoring help, including 1-2.5 kg cats. Small-bodyweight bands create relatively large exposure steps, exact quartering/ingestion must be confirmed and feline overdose sensitivity makes rounding or unsupervised repeating unacceptable.

Full-course cost-effectiveness-

Current Georgian course price was unavailable; price is excluded from the denominator.

Important safety and use flags

  • Scope boundary: this cat score covers the complete manufacturer-labelled nematode, cestode, trematode, prevention and claimed Giardia scope. Evidence is materially stronger for a narrower GI nematode+cestode core; presence of an active does not validate every listed organism/stage.
  • Diagnose/risk-assess before dosing: use faecal testing, visible segments, exposure and local epidemiology as appropriate. Echinococcus requires public-health procedures; severe hookworm disease may need stabilization and suspected treatment failure needs quantitative follow-up.
  • Exact dose: accurately weigh; give 1/4 tablet at 1-2.5 kg, 1/2 at >2.5-5 kg, 1 at >5-10 kg, then 0.1 tablet/kg in deliverable quarter increments. Give once directly or with food; no fasting/laxative. Do not round an undeliverable result.
  • Giardia boundary: one tablet/10 kg supplies fenbendazole 20 mg/kg once. This is not the multi-day fenbendazole-containing regimen described by current giardiosis guidance; do not diagnose/treat Giardia from the ingredient list or repeat empirically without diagnostic and hygiene control.
  • Broad-claim boundary: identical-strength EU dog products restrict use to defined mixed GI nematode+cestode stages and when both groups need treatment. Strongyloides, trematodes, broad larval stages and blanket prevention in this manufacturer label lack an equivalent exact-product public outcome dossier.
  • Repeat/prevention: repeat after 10-14 days only when parasite biology, diagnosis or risk indicates. Routine quarterly use is not universally optimal; tailor lifetime control to age, geography, hunting/raw diet, travel, household and faecal surveillance, limiting unnecessary selection pressure.
  • Reinfection/resistance: control fleas for Dipylidium, prey/raw offal for Taenia/Echinococcus and faecal/environment contamination. Persistent eggs/signs require adherence, reinfection, species/stage and resistance assessment—not automatic use of the same combination.
  • Do not use below 4 weeks in dogs or 6 weeks in cats, from one week before through two weeks after parturition, or in infectious disease, exhaustion/debilitation, renal/hepatic impairment or hypersensitivity. Lactation is allowed only once offspring exceed those age limits.
  • Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines. Stop/reassess clinically significant vomiting, diarrhoea, anorexia, lethargy, depression or neurologic/cholinergic signs; no specific overdose antidote is stated.
  • Feline overdose warning: the manufacturer states cats are more sensitive; depression, vomiting and diarrhoea may occur. Quarter-tablet bands yield higher mg/kg exposure at the low end, so never round up, redose after vomiting or combine dewormers without a veterinarian-directed calculation.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Formulation Type
Scored tablet
Administration route
By mouth
Manufacturer
Vetsintez Ltd · Ukraine
Manufacturer (register)
Vetsintez Ltd, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1839, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 05 Aug 2031
Veterinary (National Food Agency)
In the register: ანტიჰელმი ტრიო 0.8 გ
№ 001234
Verified on: 23 Oct 2026
EU No
UK No
US No
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified Manufacturer-labelled scope includes prevention/treatment of listed nematodes, cestodes and trematodes, with additional Giardia activity claimed in pharmacology text; evidence is substantially stronger for a narrower GI nematode+cestode scope. Give the exact weight-band dose once with food or directly; fasting/laxative is unnecessary. Repeat after 10-14 days only when diagnosis/life cycle/risk indicates. Quarter-tablet steps must be deliverable after accurate weighing.
DoseSpeciesWeightRouteFrequencySource
1/4 tablet
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
Cat 1–2.5 kg By mouth once; repeat after 10-14 days only when clinically indicated
Vetsintez instruction
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
ANTIHELM TRIO tablets - official manufacturer instruction
Vetsintez official product instruction, 2026
1/2 tablet
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
Cat 2.5–5 kg By mouth once; repeat after 10-14 days only when clinically indicated
Vetsintez instruction
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
ANTIHELM TRIO tablets - official manufacturer instruction
Vetsintez official product instruction, 2026
1 tablet
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
Cat 5–10 kg By mouth once; repeat after 10-14 days only when clinically indicated
Vetsintez instruction
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
ANTIHELM TRIO tablets - official manufacturer instruction
Vetsintez official product instruction, 2026
1 tablet per 10 kg
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
Cat over 10 kg By mouth once; repeat after 10-14 days only when clinically indicated
Vetsintez instruction
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
ANTIHELM TRIO tablets - official manufacturer instruction
Vetsintez official product instruction, 2026
1/4 tablet
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
Dog 1–2.5 kg By mouth once; repeat after 10-14 days only when clinically indicated
Vetsintez instruction
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
ANTIHELM TRIO tablets - official manufacturer instruction
Vetsintez official product instruction, 2026
1/2 tablet
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
Dog 2.5–5 kg By mouth once; repeat after 10-14 days only when clinically indicated
Vetsintez instruction
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
ANTIHELM TRIO tablets - official manufacturer instruction
Vetsintez official product instruction, 2026
1 tablet
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
Dog 5–10 kg By mouth once; repeat after 10-14 days only when clinically indicated
Vetsintez instruction
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
ANTIHELM TRIO tablets - official manufacturer instruction
Vetsintez official product instruction, 2026
1 tablet per 10 kg
Give with a small amount of food or directly into the mouth; fasting or laxatives are not required. Do not use in puppies under 4 weeks or kittens under 6 weeks, during the week before or two weeks after parturition, or in infected, debilitated animals or animals with renal or hepatic impairment. Do not combine with piperazine derivatives, levamisole, organophosphates or other cholinergic medicines.
Dog over 10 kg By mouth once; repeat after 10-14 days only when clinically indicated
Vetsintez instruction
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
ANTIHELM TRIO tablets - official manufacturer instruction
Vetsintez official product instruction, 2026
Active substance doses, with sources
Active substance Fenbendazole
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
100 mg/kg Dog, Cat Maintenance By mouth once
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Panacur small animal 100 mg/ml oral suspension - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2025
Active substance Pyrantel
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
14.4 mg/kg Dog Maintenance By mouth once
VMD SPC 2022
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Krka Multiwormer 50/144/150 mg tablets for dogs - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2022
20 mg/kg Cat Maintenance By mouth once
VMD SPC 2024
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Krka Wormer 230 mg/20 mg film-coated tablets for cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024
Active substance Praziquantel
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
5 mg/kg Dog, Cat Maintenance By mouth once
VMD SPC 2022
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Krka Multiwormer 50/144/150 mg tablets for dogs - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2022
VMD SPC 2024
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Krka Wormer 230 mg/20 mg film-coated tablets for cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024

Known Contraindications

  • Critical Praziquantel
    Do not use in cases of known hypersensitivity to the active substances or to any of the excipients.
    Sources: VMD SPC · VMD
  • Critical Pyrantel (Dog)
    Do not use in dogs younger than 2 weeks of age and/or weighing less than 2 kg.
    Sources: VMD SPC · VMD · FDA
  • Critical Pyrantel (Cat)
    Do not use in kittens less than 6 weeks of age.
    Sources: VMD SPC · VMD
  • Warning Pyrantel (Cat)
    The safety of the veterinary medicinal product has not been established during pregnancy. The product should not be used during pregnancy but may be used during lactation.
    Sources: VMD SPC · VMD

Known Drug Interactions

  • Minor warning Fenbendazole + Methimazole
    Thiamazole reduces hepatic oxidation of benzimidazole anthelmintics and can increase their plasma concentrations during concurrent treatment.
    Recommendation: Higher fenbendazole concentrations are expected during concomitant administration.

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.